Hypertension : NICE guidance summary

The NICE guideline on hypertension, titled "Hypertension in adults: diagnosis and management" (NG136), provides a comprehensive framework for identifying and managing primary hypertension (high blood pressure) in adults aged 18 and over. This includes individuals with comorbid conditions such as type 2 diabetes. Hypertension is a leading risk factor for cardiovascular diseases like heart attacks and strokes, and this guideline aims to assist healthcare professionals in both accurate diagnosis and effective treatment to mitigate these risks.

This guideline, originally published in August 2019 and updated as recently as November 2023, incorporates the latest evidence and recommendations for managing hypertension, including updates on postural hypotension measurement and management. Notably, tables have been added to summarise blood pressure targets, aligning this guidance with recommendations from related NICE guidelines on type 1 diabetes and chronic kidney disease.

The guidance emphasizes a structured approach to diagnosing hypertension, initiating and adjusting antihypertensive drug treatment, and monitoring blood pressure. It also includes recommendations on lifestyle interventions and assessing cardiovascular risk, helping clinicians make informed decisions to optimize patient outcomes.

For more detailed information on these updates, including postural hypotension and specific blood pressure targets, refer to the November 2023 update.